Original Repository: Alan Mason Chesney Medical Archives. Daniel Nathans Collection
Reproduced with permission of Joanne Nathans.
Medical Subject Headings (MeSH):
Simian virus 40
Restriction Enzymes and the "New Genetics," 1970-1980
October 8, 1975
We are preparing DNA of SV40 dl-1009 and will send you a preparation of Hirt-supernatant DNA ready for electrophoresis in
agarose gels. For quantitation the DNA is being labeled "lightly" with 3H-thymidine. The steps you outline look O.K.
to me except for recovery of the DNA from gels for endo R HindIII cleavage. HindIII is very sensitive to an "inhibitor"
in DNA recovered from agarose. We now dissolve on the gel segment in saturated KI (potassium iodide), adsorb DNA on hydroxyapatite
which has been equilibrated with saturated KI in pH 7.0-0.01 M Na phosphate, wash with saturated KI, then 0.1 M NaP, and elute
DNA with 0.4 M NaP, pH 7.0. NaP is removed by extensive dialysis of DNA against 1/10 SSC.
You should have about 50 [mu]g of dl-1009 DNA in what we send (from 20 10-cm dishes). I would be inclined to re-electrophorese
the original form I dl DNA to reduce contamination with helper and then isolate full length dl-1009 linear molecules after
partial dIII digestion for coupling to [lambda] DNA. (First determine conditions for partial digestion.) The mixture of linears
and presence of an intact VP1 (or B/c) gene can be predicted from the following map of dl-1009:
As you see, several fragments will have an intact B/c (probably VP1) gene. Of course all can be cloned and readily distinguished
one from the other by digestion of the [lambda]-SV40 hybrid and especially by heteroduplex mapping.
Best of luck. Let me know if I can be of further help. Also please keep me informed of progress.